Bassem Refaat

26PUBLICATIONS
54CO-AUTHORS
Pharmaceutical delivery technologiesPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biologically active moleculesMedical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Sep 26, 2026
Octreotide-Mediated Co-Solubilization of Paclitaxel and Docetaxel: A Novel Targeted Formulation for Synergistic Anticancer Chemotherapy.

|May 19, 2026
The GLP-1 Receptor Agonist Liraglutide Promotes Anticancer Activities in MCF7 Breast and PC-3 Prostate Cancer Cells by Modulating Glycolysis, Oxidative Stress and Adipokines.

|Mar 28, 2025
IL-10-Directed Cancer Immunotherapy: Preclinical Advances, Clinical Insights, and Future Perspectives.

Adel G El-Shemi, Afnan Alqurashi, Jihan Abdullah Abdulrahman

|Oct 25, 2024
Cytotoxic activity, selectivity, and clonogenicity of fruits and resins of Saudi medicinal plants against human liver adenocarcinoma.

Ali Hendi Alghamdi, Aimun A E Ahmed, Mahadi Bashir

|Oct 13, 2024
Enhanced hepatoprotective effects of empagliflozin and vitamin D dual therapy against metabolic dysfunction-associated steatohepatitis in mice by boosted modulation of metabolic, oxidative stress, and inflammatory pathways.

Wesam F Farrash, Shakir Idris, Mohamed E Elzubier

|Dec 23, 2023
Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus.

Abdulrahman Mujalli, Wesam F Farrash, Ahmad A Obaid

Pageof 5

Frequent Collaborators

5 joint publications

Riyad Almaimani

4 joint publications

Mahmoud Zaki El-Readi

4 joint publications

Akhmed Aslam

3 joint publications

Ashraf N Abdalla